MCID: DNG002
MIFTS: 55

Dengue Hemorrhagic Fever malady

Infectious diseases category

Aliases & Classifications for Dengue Hemorrhagic Fever

About this section

Aliases & Descriptions for Dengue Hemorrhagic Fever:

Name: Dengue Hemorrhagic Fever 32 10 47 12 2
Severe Dengue 65 36
 
Dhf 10 2


Classifications:



External Ids:

Disease Ontology10 DOID:12206
NCIt42 C34683
MeSH36 D019595
ICD1027 A91

Summaries for Dengue Hemorrhagic Fever

About this section
Disease Ontology:10 A dengue disease that occurs when a person experiences a second infection with a heterologous dengue virus serotype, which is transmitted by aedes mosquito bite. the infection has symptom hemorrhagic lesions of the skin, has symptom thrombocytopenia, has symptom reduction in the fluid part of the blood, and has symptom high fever.

MalaCards based summary: Dengue Hemorrhagic Fever, also known as severe dengue, is related to hepatitis and acute myocarditis, and has symptoms including hemorrhagic lesions of the skin, thrombocytopenia and reduction in the fluid part of the blood. An important gene associated with Dengue Hemorrhagic Fever is CD209 (CD209 Molecule), and among its related pathways are IL-10 Pathway and IL-15 Signaling and its Primary Biological Effects in Different Immune Cell Types. Affiliated tissues include skin, t cells and bone, and related mouse phenotypes are liver/biliary system and digestive/alimentary.

Related Diseases for Dengue Hemorrhagic Fever

About this section

Diseases related to Dengue Hemorrhagic Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 365)
idRelated DiseaseScoreTop Affiliating Genes
1hepatitis31.0CXCL8, IFNG, IL10, TNF
2acute myocarditis30.6CD40LG, F2
3diabetic ketoacidosis30.6CXCL8, IL6
4acquired immunodeficiency syndrome30.6IL10, IL6, TNF
5pneumonia30.5CXCL8, IL6, TNF
6typhoid fever30.5ALB, CD40LG
7cholecystitis30.4ALB, CD40LG, F2, HLA-B
8congenital heart disease30.3HLA-B, IFNG, IL6, TNF
9noonan syndrome 230.2HLA-A, HLA-B, TNF
10viral infectious disease30.1ALB, CD40LG, F2, TNF
11malaria29.0ALB, CD40LG, CXCL8, F3, FCGR2A, HLA-A
12hemorrhagic fever11.6
13dengue shock syndrome10.9
14thrombocytopenia10.8
15endotheliitis10.7
16pancreatitis10.6
17encephalopathy10.6
18hemophagocytic lymphohistiocytosis10.5
19diastolic heart failure10.5
20pituitary apoplexy10.5
21acute pancreatitis10.5
22myocarditis10.5
23dengue disease10.4
24acalculous cholecystitis10.4
25japanese encephalitis10.4
26atrial fibrillation10.4
27compartment syndrome10.4
28encephalitis10.4
29non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency10.4ALB, F2
30diffuse idiopathic skeletal hyperostosis10.3F2, F3
31relapsing polychondritis10.3F2, F3
32punctate porokeratosis10.3IL10, TNF
33irritable bowel syndrome10.3F2, F3
34primary progressive freezing gait10.3IL10, TNF
35congestive heart failure10.3
36venezuelan hemorrhagic fever10.3F3, STAT1
37complement deficiency10.3ALB, F2, TNF
38barrett's adenocarcinoma10.3F2, F3
39tall stature - scoliosis - macrodactyly of the great toes10.3F2, F3
40microsomia hemifacial radial defects10.3IL10, TNF
41venous insufficiency10.3ALB, F2, F3
42multifocal lymphangioendotheliomatosis with thrombocytopenia10.3IL10, TNF
43opioid abuse10.3ALB, F2, TNF
44stargardt macular degeneration absent or hypoplastic corpus callosum mental retardation and dysmorphic features10.3IFNG, TNF
45intracranial sinus thrombosis10.3F2, F3, TNF
46autoimmune oophoritis10.2IFNG, TNF
47sensorineural hearing loss10.2IFNG, IL10
48intrapelvic lymph node leukemic reticuloendotheliosis10.2IL10, TNF
49best1 retinopathy10.2IFNG, TNF
50systolic heart failure10.2

Graphical network of the top 20 diseases related to Dengue Hemorrhagic Fever:



Diseases related to dengue hemorrhagic fever

Symptoms for Dengue Hemorrhagic Fever

About this section

Symptoms:

 10
  • hemorrhagic lesions of the skin
  • thrombocytopenia
  • reduction in the fluid part of the blood
  • high fever

Drugs & Therapeutics for Dengue Hemorrhagic Fever

About this section

Drugs for Dengue Hemorrhagic Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IvermectinapprovedPhase 2, Phase 34570288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
2Insect RepellentsPhase 32
3
NeomycinapprovedPhase 1, Phase 2371404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
 
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neo-fradin
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Theraplusplus Plus
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
4
RibavirinapprovedPhase 291436791-04-537542
Synonyms:
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide
36791-04-5
437710-49-1
66510-90-5
AA-504/07617051
AB00430481
AC1L1XXZ
AC1Q1IDC
AC1Q4ZGS
AKOS001715163
BB_NC-0567
BPBio1_001195
BRN 0892462
BSPBio_001085
BSPBio_003352
C-Virin
CHEMBL1643
CID37542
Copegus
Copegus (TN)
Cotronak
D00423
DB00811
DRG-0028
DivK1c_000782
Drug: Ribavirin
EU-0101063
FT-0082885
HMS2090L15
HMS2094O09
HMS502H04
HSDB 6513
ICN-1229
IDI1_000782
Ibavyr
KBio1_000782
KBio2_002328
KBio2_004896
KBio2_007464
KBio3_002854
KBioGR_001804
KBioSS_002331
KS-1104
LS-1241
Lopac0_001063
MLS000028486
MLS002222317
Moderiba
MolPort-002-507-104
MolPort-002-885-856
NCGC00090726-01
NCGC00090726-03
NCGC00090726-04
NCGC00090726-05
NCGC00090726-06
NCGC00090726-07
NINDS_000782
 
NSC 163039
NSC163039
Prestwick3_000993
R 9644
R-964
R9644_SIGMA
RBV
RG-964
RIBAV
RTC
RTCA
RTP
Ravanex
Rebetol
Rebetol (TN)
Rebetron
Rebretron
Ribacine
Ribamide
Ribamidil
Ribamidyl
Ribasphere
Ribasphere (TN)
Ribasphere Ribapak
Ribav
Ribavirin
Ribavirin (JAN/USP/INN)
Ribavirin Capsules
Ribavirin Triphosphate
Ribavirin [USAN:INN]
Ribavirin-TP
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirinum
Ribavirinum [INN-Latin]
Ribovirin
Ro 20-9963/000
Ro-20-9963
S2504_Selleck
SCH 18908
SMP1_000261
SMR000058315
SPECTRUM1503938
SR-01000076112-3
Spectrum3_001876
Spectrum4_001252
Spectrum5_002075
Spectrum_001826
Tribavirin
UNII-49717AWG6K
Varazid
Vilona
Viramid
Viramide
Virazid
Virazide
Virazole
Virazole (Ribavirin) Inhalation Solution
Virazole (TN)
Virazole 5'-triphosphate
ZINC01035331
ribavirin
5
HydrocortisoneapprovedPhase 255050-23-75754, 657311
Synonyms:
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
1 Hydrocortisone maximum strength
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11β-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
999 Itch Relieving
A-hydrocort
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Advanced Hydrocortisone
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti Itch
Anti Itch maximum strength
Anti Itch maximum strength plus
Anti-inflammatory hormone
Anti-itch
Anti-itch Scalp Relief Maximum Strength
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Apres Peel Soothing Balm
Aquacort
Aquanil HC
Atopalm Maximum Strength Anti-itch
Atopalm Moisturizing Hydrocortisone
Aveeno Hydrocortisone Anti Itch
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
Bioelements Immediate Comfort Hydrocortisone
Budpak Anti-itch
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Caldecort
Care One Hydrocortisone maximum strength
Cetacort
Chronocort
Cicatricure Ultra Moisturizing
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortaid 12-hour Advanced Anti-Itch
Cortaid Intensive Therapy Cooling
Cortaid Maximum Strength
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisone
Cortisone Cream Intensive Healing
Cortisone Maximum Strength
Cortisone maximum strength
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortizone 10
Cortizone 10 Cooling Cream Anti-itch
Cortizone 10 Cooling Relief
Cortizone 10 Easy Relief
Cortizone 10 Hydratensive Healing Anti Itch
Cortizone 10 Hydratensive Soothing Anti Itch
Cortizone 10 Intensive Healing
Cortizone 10 Intensive Healing Feminine Itch Relief
Cortizone 10 Intensive Healing For Eczema
Cortizone 10 Plus
Cortizone 10 Poison Ivy Relief Pads
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cvs Anti-itch Hydrocortisone
Cvs Cools Itch Fast
Cvs Cortisone
Cvs Pharmacy Anti-itch
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermacort Anti-Itch
Dermaquest Skin Therapy Post-skin Resurfacing Balm
Dermarest Eczema Medicated
Dermaspray
Dermil
Dermocortal
Dermolate
Dg Health Hydrocortisone
Dg Health Hydrocortisone Cream Maximum Strength
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Dr. Sheffield Hydrocortisone Anti Itch
Drotic
Duane Reade
Duane Reade hydrocortisone
Duane Reade hydrocortisone plus 12 moisturizers
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Equaline Anti Itch
Equaline Anti Itch maximum strength
Equate Hydrocortisone
Esiderm H
Evacort
Family Care Hydrocortisone
Family Wellness
Family Wellness Hydrocortisone
Family Wellness Maximum Strength Hydrocortisone
Ficortril
Fiocortril
Fixmyskin Healing Balm Fragrance-free
Fixmyskin Healing Balm Unflavored
Fixmyskin Healing Balm Vanilla Flavor
Fixmyskin Healing Balm Vanilla Fragrance
Flexicort
Foille Insetti
Formu Care Anti Itch maximum strength
Fulton Street Market Anti Itch
Genacort
Genacort (lotion)
Genuine Hydrocortisone
Glycort
Good Neighbor Pharmacy Anti Itch
Good Neighbor Pharmacy Hydrocortisone
Good Neighbor Pharmacy Hydrocortisone Plus 12 Moisturizers
Good Sense Anti Itch
Gyno-Cortisone
H 4001
H-Cort
H-releve Anti-itch
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Healerz For Itches
Health Mart Pharmacy Hydrocortisone Maximum Strength Plus 12 Moisturizers
Healthy Accents Cortisone maximum strength
Heb Cort
Heb-Cort
 
Hem-easy Relief Herbal Anti-itch Maximum Itch Relief
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro Skin
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone 1 plus 10
Hydrocortisone Acetate
Hydrocortisone Anti-itch Plus
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone D
Hydrocortisone HC
Hydrocortisone Intensive Healing Formula
Hydrocortisone Maximum Strength
Hydrocortisone Maximum Strength Plus 12 Moisturizers
Hydrocortisone Plus
Hydrocortisone Plus 12 Moisturizers
Hydrocortisone Probutate
Hydrocortisone Regular Strength
Hydrocortisone Sodium Phosphate
Hydrocortisone Ultra Strength
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone anti itch
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone maximum strength
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Intensive Healing Anti Itch
Kaiser Permanente Hydrocortisone
Kendall'S compound F
Kendall's compound F
Kera Hc Hydrocortisone
Kirkland Signature Hydrocortisone Plus maximum strength
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Leader Hydrocortisone
Locoid
Loesch Anti-Itch Therapy
Lopac0_000594
Lubricort
Lucky Supersoft MAXIMUM STRENGTH
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Makesense MAXIMUM STRENGTH
Maximum Strength Cortizone 10 Quick Shot 360 Continuous
Maximum Strength Hydrocortisone
Maximum-h
Medicort
Medpride
Meijer Anti Itch
Meijer Anti Itch Cream Plus
Meijer Hydrocortisone
Meijer Hydrocortisone Plus 12 Moisturizers
Members Mark Hydrocortisone
Meusicort
Mildison
Milliderm
MolPort-001-794-637
Monistat Complete Care Instant Itch Relief
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Natureplex Hydrocortisone Hydro
Neo-Cort-Dome
Neo-Cortef
Neosporin Eczema Essentials Anti Itch
Neosporin-H Ear
Nogenic HC
Nu-derm Tolereen Anti-pruritic
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pandel
Pediaderm Hc
Pediotic Suspension
Penecort
Permicort
Piyanping Antiitch
Polcort H
Premier Value Hydrocortisone
Premier Value Hydrocortisone Plus 12 Moisturizers
Preparation H Hydrocortisone
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proactiv Solution Anti-itch Scalp
Procto-pak
Proctocort
Proctocream HC
Proctofoam
Proctosol-hc
Proctozone HC
Procure
Protocort
Publix Hydro
Publix hydro plus
Quadrydern
Quality Choice Hydrocortisone
Quality Choice Hydrocortisone Maximum Strength
Quality Choice Maximum Strength Anti Itch
Racet
Rectasol-HC
Rectoid
Refuge Hc
Reichstein'S substance M
Reichstein's substance M
Remederm HC
Rexall Anti Itch maximum strength relief
Rexall Hydrocortisone 1
Rexall Hydrocortisone plus moisturizers
Rite Aid anti-itch
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Safeway Hydrocortisone Plus 12 Moisturizers
Sanatison
Scalp-Cort
Scalpicin Anti-Itch Maximum Strength
Scalpicin Capilar
Scalpicin Maximum Strength
Scalpicin Scalp Itch Medication Maximum Strength
Schericur
Scheroson F
Shopko Hydrocortisone
Shopko Hydrocortisone Intensive Healing Formula
Shopko Hydrocortisone Maximum Strength
Shopko Hydrocortisone Plus 12 Moisturizers Maximum Strength
Shopko Maximum Strength
Shoprite Hydrocortisone
Sigmacort
Signef
Smart Sense Anti Itch
Smart Sense Anti Itch maximum strength
Smart Sense Hydrocortisone
Solu-cortef
Soothe Rodan Fields
Stie-cort
Stiefcorcil
Sunmark Hydrocortisone
Sunmark Hydrocortisone Plus 12 Moisturizers
Synacort
Systral Hydrocort
Tarcortin
Tecnu Corticool
Texacort
Texacort lotion 25
Thera Plus
Timocort
Topcare Hydrocortisone
Topcare Hydrocortisone Intensive Healing Formula
Topcare Hydrocortisone Plus 12 Moisturizers
Topicort
Transderma H
Traumaide
Truelipids Anti-itch Barrier
U-cort
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Walgreens Hydrocortisone Plus 12 Moisturizers
Westcort
Western Family HydroCortisone
Western Family HydroCortisone Plus 12 Moisturizers
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
6
chloroquineapprovedPhase 1, Phase 213754-05-72719
Synonyms:
( -)-Chloroquine
(+)-Chloroquine
(-)-Chloroquine
(R)-(-)-Chloroquine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
Bemaco
Bemaphate
Bemasulph
Benaquin
Bipiquin
C07625
C18H26ClN3
CCRIS 3439
CHEBI:3638
CHEMBL76
CID2719
CQ
CU-01000012392-2
Capquin
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine Bis-Phosphoric Acid
Chloroquine Phosphate
Chloroquine [USAN:INN:BAN]
Chloroquine phosphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
D02366
DB00608
Dawaquin
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
HMS2090O03
HSDB 3029
Heliopar
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
Ipsen 225
 
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
LS-141726
Lapaquin
Lopac0_000296
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
NCI60_000894
NINDS_000404
NSC 187208
NSC14050
NSC187208
Neochin
Nivachine
Nivaquine
Nivaquine B
Nivaquine b
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
RP 3377
RP-3377
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
SMP2_000034
SN 6718
SN-7618
SPBio_000174
SPBio_002516
ST 21
ST 21 (pharmaceutical)
Sanoquin
Silbesan
Siragan
Solprina
Sopaquin
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
Spectrum_000132
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
chloroquine
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
7AlbunexPhase 2, Phase 1145
8CoagulantsPhase 2983
9Hydrocortisone-17-butyratePhase 2550
10Hydrocortisone acetatePhase 2550
11Hydrocortisone 17-butyrate 21-propionatePhase 2550
12Cortisol succinatePhase 2550
13Chloroquine diphosphatePhase 1, Phase 213750-63-5
14AnthelminticsPhase 1, Phase 2363
15
Aluminum hydroxideapprovedPhase 1169
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
16Aluminum sulfatePhase 177
17
Permethrinapproved, investigational2552645-53-140326
Synonyms:
(+)-CIS-PERMETHRIN
(+)-trans-Permethrin
(+-)-cis-Fmc 33297
(+-)-cis-Permethrin
(+-)-trans-Permethrin
(3-Phenoxyphenyl)methyl (+-)-cis,trans-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
1RS,cis-Permethrin
1RS-trans-Permethrin
3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropane carboxylic acid, (3-phenoxyphenyl) methyl ester
3-Phenoxybenzyle (1RS)-cis, trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylate
3-phenoxybenzyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
442748_SUPELCO
45614_FLUKA
45614_RIEDEL
45893_FLUKA
45893_RIEDEL
47956_SUPELCO
52341-32-9
52341-33-0
52645-53-1
AC1L23IC
AC1Q3FFG
AI3-29296
Acticin Cream
Ambush
BRN 4153590
C21H20Cl2O3
CHEBI:34911
CHEMBL1525
CID40326
DB04930
Elimite
Elimite Cream
Equaline Lice Treatment
FMC 35171
 
Good Neighbor Pharmacy Lice Treatment
Good Sense Lice Treatment
LS-58636
LS-58640
Leader Lice Treatment
Lice Treatment
MLS001332525
MLS001332526
MolPort-003-933-021
NCGC00159390-00
NCGC00159390-02
NCGC00159390-04
NCGC00159390-05
NCGC00159390-06
NCGC00159390-07
NCGC00159390-08
NCGC00159390-09
NRDC 146
NRDC 148
Nix
Nix Complete Maximum Strength Lice Elimination
Nix Cream Rinse
PS758_SUPELCO
PerFoam
Permethrin
Permethrin (isomers)
Permethrin (isomers) solution
Permethrine,c&t
SMR000778043
ST50975270
Smart Sense Lice Treatment
TL8003462
Topcare Lice Treatment
Transpermethrin
Transpermethrin [ISO]
[3-(phenyloxy)phenyl]methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
trans-(+-)-Permethrin
18Rho(D) Immune Globulin198
19Immunoglobulins, Intravenous203

Interventional clinical trials:

(show top 50)    (show all 116)
idNameStatusNCT IDPhase
1Ketotifen as a Treatment for Vascular Leakage During Dengue FeverRecruitingNCT02673840Phase 4
2Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)Not yet recruitingNCT02555072Phase 4
3Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaCompletedNCT01134263Phase 3
4Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCompletedNCT01436396Phase 3
5Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersCompletedNCT01411241Phase 3
6Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in MalaysiaCompletedNCT01254422Phase 3
7Efficacy and Safety of Ivermectin Against Dengue InfectionRecruitingNCT02045069Phase 2, Phase 3
8Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue VaccineRecruitingNCT02406729Phase 3
9Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDRRecruitingNCT00938379Phase 3
10Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in AsiaActive, not recruitingNCT01373281Phase 3
11Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin AmericaActive, not recruitingNCT01374516Phase 3
12Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)Active, not recruitingNCT00966628Phase 3
13Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic FeverCompletedNCT01601613Phase 2
14Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCompletedNCT01488890Phase 2
15A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCompletedNCT01064141Phase 2
16Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaCompletedNCT01550289Phase 2
17Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaCompletedNCT00993447Phase 2
18Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in SingaporeCompletedNCT00880893Phase 2
19Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaCompletedNCT01187433Phase 2
20Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCompletedNCT00730288Phase 2
21Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCompletedNCT00875524Phase 2
22Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCompletedNCT00842530Phase 2
23Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCompletedNCT00617344Phase 2
24Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsCompletedNCT00740155Phase 2
25Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCompletedNCT00788151Phase 2
26A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and ChildrenCompletedNCT00468858Phase 2
27A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive InfantsCompletedNCT00322049Phase 1, Phase 2
28A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00239577Phase 2
29A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US AdultsCompletedNCT00350337Phase 2
30A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in ThailandCompletedNCT00370682Phase 2
31A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive ChildrenCompletedNCT01843621Phase 1, Phase 2
32Celgosivir as a Treatment Against DengueCompletedNCT01619969Phase 1, Phase 2
33Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompletedNCT01218906Phase 2
34A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve ChildrenCompletedNCT00384670Phase 1, Phase 2
35Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)CompletedNCT02193087Phase 2
36Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineRecruitingNCT01943825Phase 2
37Chinese and Western Medicine Treatment of Fever Associated With Bleeding SymptomsRecruitingNCT01973855Phase 2
38Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US AdultsRecruitingNCT02421367Phase 1, Phase 2
39Safety and Immunogenicity With Two Different Serotype 2 Potencies of Tetravalent Dengue Vaccine (TDV) in Adults in SingaporeRecruitingNCT02425098Phase 2
40Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in ThailandRecruitingNCT02332733Phase 2
41Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy ParticipantsActive, not recruitingNCT02302066Phase 2
42Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) VaccineActive, not recruitingNCT01696422Phase 2
43The Effect of Chloroquine in the Treatment of Patients With DengueActive, not recruitingNCT00849602Phase 1, Phase 2
44The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansActive, not recruitingNCT01943305Phase 2
45Immunogenicity and Safety of 3-Dose and Booster Dose of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeNot yet recruitingNCT02628444Phase 2
46Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleNot yet recruitingNCT02623725Phase 2
47Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in SingaporeNot yet recruitingNCT02569827Phase 1, Phase 2
48Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, BangladeshNot yet recruitingNCT02678455Phase 2
49Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue VirusCompletedNCT00458120Phase 1
50Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue VirusCompletedNCT00919178Phase 1

Search NIH Clinical Center for Dengue Hemorrhagic Fever


Cochrane evidence based reviews: Severe Dengue

Genetic Tests for Dengue Hemorrhagic Fever

About this section

Anatomical Context for Dengue Hemorrhagic Fever

About this section

MalaCards organs/tissues related to Dengue Hemorrhagic Fever:

33
Skin, T cells, Bone, Kidney, Thyroid, Pituitary, Liver

Animal Models for Dengue Hemorrhagic Fever or affiliated genes

About this section

MGI Mouse Phenotypes related to Dengue Hemorrhagic Fever:

38 (show all 15)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.8ALB, IFNG, IL10, IL6, STAT1, TNF
2MP:00053818.6ALB, F2, IFNG, IL10, IL6, STAT1
3MP:00053908.2CD40LG, F2, FCGR2A, IFNG, IL10, IL6
4MP:00053698.0ALB, F3, IFNG, IL10, IL6, STAT1
5MP:00107718.0CD40LG, F2, F3, IFNG, IL10, IL6
6MP:00053797.9ALB, CD40LG, IFNG, IL10, IL6, TLR3
7MP:00020067.8ALB, F3, IFNG, IL10, IL6, STAT1
8MP:00053847.8ALB, CD40LG, F2, F3, IFNG, IL10
9MP:00053857.5CD40LG, F2, F3, IFNG, IL10, IL6
10MP:00053766.8ALB, CD209, CD40LG, F2, F3, IFNG
11MP:00036316.5CD40LG, F2, F3, HLA-B, IFNG, IL10
12MP:00107685.2ALB, CD209, CD40LG, F2, F3, FCGR2A
13MP:00053975.0CD40LG, CXCL8, F2, F3, FCGR2A, HLA-B
14MP:00053874.9CD209, CD40LG, CXCL8, F2, F3, FCGR2A

Publications for Dengue Hemorrhagic Fever

About this section

Articles related to Dengue Hemorrhagic Fever:

(show top 50)    (show all 468)
idTitleAuthorsYear
1
Morbidity Rate Prediction of Dengue Hemorrhagic Fever (DHF) Using the Support Vector Machine and the Aedes aegypti Infection Rate in Similar Climates and Geographical Areas. (25961289)
2015
2
Frosted Branch Angiitis in a Patient Coinfected With Dengue Hemorrhagic Fever and Malaria. (26067694)
2015
3
Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever. (26175069)
2015
4
Association of combinations of interleukin-10 and pro-inflammatory cytokine gene polymorphisms with dengue hemorrhagic fever. (25890879)
2015
5
Hemostatic derangement in dengue hemorrhagic fever. (24120237)
2014
6
Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. (24305068)
2013
7
Acute pancreatitis in dengue hemorrhagic fever. (22451187)
2012
8
Use of pentoxifylline in treatment of children with dengue hemorrhagic fever. (22481426)
2012
9
Persistent thrombocytopenia in dengue hemorrhagic fever. (21992910)
2011
10
Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. (20205587)
2010
11
Clinical characteristics, risk factors, and outcomes in adults experiencing dengue hemorrhagic fever complicated with acute renal failure. (19346394)
2009
12
Dengue hemorrhagic fever complicated with encephalopathy and myocarditis: a case report. (19245163)
2008
13
Dengue and dengue hemorrhagic fever: management issues in an intensive care unit. (17530136)
2007
14
Difficulty in diagnosis and treatment of dengue hemorrhagic fever in patients with chronic renal failure: report of three cases of mortality. (17426183)
2007
15
T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? (16517753)
2006
16
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. (16983615)
2006
17
Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. (17090900)
2006
18
Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. (15964964)
2005
19
The emergence of epidemic dengue fever and dengue hemorrhagic fever in the Americas: a case of failed public health policy. (15969972)
2005
20
Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. (15827272)
2005
21
Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobulin. (12802766)
2003
22
Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. (12727523)
2003
23
Coagulation abnormalities in dengue hemorrhagic Fever: serial investigations in 167 Vietnamese children with Dengue shock syndrome. (12115093)
2002
24
Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. (12224589)
2002
25
The dengue and dengue hemorrhagic fever epidemic in Puerto Rico, 1994-1995. (11425166)
2001
26
The risk of dengue hemorrhagic fever (DHF) outbreak based on vector density in Kurau, Riau province, Indonesia. (11414442)
2000
27
A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. (11127322)
2000
28
Determining the incidence of dengue hemorrhagic fever in Puerto Rico. (10730299)
1999
29
A clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. (10928368)
1999
30
Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. (10515800)
1999
31
Gallbladder wall thickening in dengue hemorrhagic fever: an ultrasonographic study. (7673451)
1995
32
Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. (7886587)
1993
33
The first epidemic of dengue hemorrhagic fever in the People's Republic of China. (2042704)
1991
34
Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. (2316788)
1990
35
International symposium on dengue and dengue hemorrhagic fever. Introduction. (1983048)
1990
36
Global epidemiology of dengue hemorrhagic fever. (2098928)
1990
37
Association of dengue hemorrhagic fever with the HLA system. (3498669)
1987
38
Dengue hemorrhagic fever--Puerto Rico. (3097497)
1986
39
Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. (2989309)
1985
40
Atypical lymphocyte in dengue hemorrhagic fever: its value in diagnosis. (6740378)
1984
41
Surveillance of dengue hemorrhagic fever cases in Thailand. (7342320)
1981
42
Dengue hemorrhagic fever in Malaysia: the 1973 epidemic. (6105712)
1980
43
Early recognition of severe dengue hemorrhagic fever. (632709)
1978
44
Glomerular changes in dengue hemorrhagic fever. (786215)
1976
45
Immunofluorescent staining of the surfaces of lymphocytes in suspension from patients with dengue hemorrhagic fever. (61729)
1976
46
Dengue hemorrhagic fever: hospital reporting taken as an index of health education effectiveness. (140560)
1976
47
Indirect fluorescent antibody technic for demonstration of serum antibody in dengue hemorrhagic fever cases. (1099896)
1975
48
Detection of sporadic cases of dengue hemorrhagic fever. (5501443)
1970
49
Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. (5419206)
1970
50
Observations related to pathogenesis of dengue hemorrhagic fever. V. Examination of agspecific sequential infection rates using a mathematical model. (5419207)
1970

Variations for Dengue Hemorrhagic Fever

About this section

Expression for genes affiliated with Dengue Hemorrhagic Fever

About this section
LifeMap Discovery
Genes differentially expressed in tissues of Dengue Hemorrhagic Fever patients vs. healthy controls: 32 (show all 120)
id Gene Description Tissue Up/Dn Fold Change (log2) P value
1CD38CD38 moleculeBlood+4.800.000
2IFI27interferon, alpha-inducible protein 27Blood+4.710.000
3RRM2ribonucleotide reductase M2Blood+4.630.000
4IGHMimmunoglobulin heavy constant muBlood+4.610.000
5BIRC5baculoviral IAP repeat containing 5Blood+4.470.000
6CAV1caveolin 1, caveolae protein, 22kDaBlood+4.410.000
7DLGAP5discs, large (Drosophila) homolog-associated protein 5Blood+4.310.000
8XISTX inactive specific transcript (non-protein coding)Blood-4.310.023
9CEP55centrosomal protein 55kDaBlood+4.280.000
10BUB1BUB1 mitotic checkpoint serine/threonine kinaseBlood+4.210.000
11SHCBP1SHC SH2-domain binding protein 1Blood+4.130.000
12PBKPDZ binding kinaseBlood+4.130.000
13IGKV3-20immunoglobulin kappa variable 3-20Blood+4.130.000
14TYMSthymidylate synthetaseBlood+4.070.000
15CDCA2cell division cycle associated 2Blood+4.060.000
16MKI67marker of proliferation Ki-67Blood+4.000.000
17CYAT1immunoglobulin lambda light chain-likeBlood+3.980.000
18MCM10minichromosome maintenance 10 replication initiation factorBlood+3.980.000
19NOVnephroblastoma overexpressedBlood-3.970.000
20ZWINTZW10 interacting kinetochore proteinBlood+3.960.000
21CDK1cyclin-dependent kinase 1Blood+3.920.000
22HMMRhyaluronan-mediated motility receptor (RHAMM)Blood+3.900.000
23SDC1syndecan 1Blood+3.890.000
24SPC25SPC25, NDC80 kinetochore complex componentBlood+3.840.000
25NCAPGnon-SMC condensin I complex, subunit GBlood+3.840.000
26TK1thymidine kinase 1, solubleBlood+3.820.000
27CDC20cell division cycle 20Blood+3.800.000
28TNFRSF17tumor necrosis factor receptor superfamily, member 17Blood+3.800.000
29DTLdenticleless E3 ubiquitin protein ligase homolog (Drosophila)Blood+3.800.000
30TOP2Atopoisomerase (DNA) II alphaBlood+3.800.000
31PI3peptidase inhibitor 3, skin-derivedBlood-3.760.000
32GLDCglycine dehydrogenase (decarboxylating)Blood+3.750.000
33IGLJ3immunoglobulin lambda joining 3Blood+3.750.000
34SESN3sestrin 3Blood-3.750.000
35KIF2Ckinesin family member 2CBlood+3.740.000
36CDT1chromatin licensing and DNA replication factor 1Blood+3.720.000
37CDKN3cyclin-dependent kinase inhibitor 3Blood+3.710.000
38KIAA0101KIAA0101Blood+3.710.000
39EIF1AYeukaryotic translation initiation factor 1A, Y-linkedBlood+3.710.034
40CNTNAP3contactin associated protein-like 3Blood-3.700.000
41CENPAcentromere protein ABlood+3.690.000
42TTKTTK protein kinaseBlood+3.670.000
43ASPMabnormal spindle microtubule assemblyBlood+3.660.000
44KIF11kinesin family member 11Blood+3.640.000
45IGLimmunoglobulin lambda locusBlood+3.640.000
46CCNB2cyclin B2Blood+3.610.000
47BUB1BBUB1 mitotic checkpoint serine/threonine kinase BBlood+3.600.000
48CDC6cell division cycle 6Blood+3.600.000
49SLC2A5solute carrier family 2 (facilitated glucose/fructose transporter), member 5Blood+3.600.000
50DUSP5dual specificity phosphatase 5Blood+3.600.000
51GGHgamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)Blood+3.570.000
52CCNA2cyclin A2Blood+3.560.000
53IGLV2-23immunoglobulin lambda variable 2-23Blood+3.550.000
54SELENBP1selenium binding protein 1Blood-3.550.000
55MELKmaternal embryonic leucine zipper kinaseBlood+3.540.000
56GINS2GINS complex subunit 2 (Psf2 homolog)Blood+3.530.000
57CHEK1checkpoint kinase 1Blood+3.510.000
58UHRF1ubiquitin-like with PHD and ring finger domains 1Blood+3.500.000
59E2F8E2F transcription factor 8Blood+3.490.000
60KDM5Dlysine (K)-specific demethylase 5DBlood+3.490.028
61RPS4Y1ribosomal protein S4, Y-linked 1Blood+3.480.048
62CCNB1cyclin B1Blood+3.450.000
63SEC61A1Sec61 translocon alpha 1 subunitBlood+3.420.000
64CNTNAP3Bcontactin associated protein-like 3BBlood-3.410.000
65E2F7E2F transcription factor 7Blood+3.410.000
66HJURPHolliday junction recognition proteinBlood+3.400.000
67OR2W3olfactory receptor, family 2, subfamily W, member 3Blood-3.390.000
68IGLV1-44immunoglobulin lambda variable 1-44Blood+3.380.000
69NCOA3nuclear receptor coactivator 3Blood+3.370.000
70JAZF1JAZF zinc finger 1Blood-3.370.000
71KIF18Bkinesin family member 18BBlood+3.360.000
72ELL2elongation factor, RNA polymerase II, 2Blood+3.360.000
73SLC16A14solute carrier family 16, member 14Blood+3.350.001
74PDZK1IP1PDZK1 interacting protein 1Blood-3.330.001
75KIF20Akinesin family member 20ABlood+3.320.000
76TPX2TPX2, microtubule-associatedBlood+3.320.000
77ITM2Cintegral membrane protein 2CBlood+3.310.000
78UCHL1ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)Blood+3.310.000
79TRIP13thyroid hormone receptor interactor 13Blood+3.300.000
80KIF15kinesin family member 15Blood+3.280.000
81AURKBaurora kinase BBlood+3.270.000
82KIF4Akinesin family member 4ABlood+3.260.000
83GTSE1G-2 and S-phase expressed 1Blood+3.260.000
84CDCA5cell division cycle associated 5Blood+3.250.000
85ESPL1extra spindle pole bodies like 1, separaseBlood+3.240.000
86GINS1GINS complex subunit 1 (Psf1 homolog)Blood+3.230.000
87ANLNanillin actin binding proteinBlood+3.230.000
88PKHD1L1polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1Blood+3.210.000
89RAD51AP1RAD51 associated protein 1Blood+3.200.000
90KLHL14kelch-like family member 14Blood+3.190.000
91CCND2cyclin D2Blood+3.170.000
92MANEAmannosidase, endo-alphaBlood+3.170.000
93DSC2desmocollin 2Blood-3.170.000
94ALDH1L2aldehyde dehydrogenase 1 family, member L2Blood+3.160.000
95SEC24ASEC24 homolog A, COPII coat complex componentBlood+3.160.000
96FOXM1forkhead box M1Blood+3.150.000
97IGKV1D-13immunoglobulin kappa variable 1D-13Blood+3.150.000
98RAD51RAD51 recombinaseBlood+3.140.000
99IGLV4-60immunoglobulin lambda variable 4-60Blood+3.140.000
100OIP5Opa interacting protein 5Blood+3.130.000
101TUBB2Atubulin, beta 2A class IIaBlood-3.130.000
102IGF1insulin-like growth factor 1 (somatomedin C)Blood+3.130.000
103DERL3derlin 3Blood+3.120.000
104MBNL3muscleblind-like splicing regulator 3Blood-3.120.000
105DENND5BDENN/MADD domain containing 5BBlood+3.110.001
106KRT1keratin 1, type IIBlood-3.100.002
107MCM4minichromosome maintenance complex component 4Blood+3.100.000
108LAMC1laminin, gamma 1 (formerly LAMB2)Blood+3.090.000
109KCTD14potassium channel tetramerization domain containing 14Blood+3.090.000
110NUSAP1nucleolar and spindle associated protein 1Blood+3.080.000
111KIF14kinesin family member 14Blood+3.080.000
112MYDGFmyeloid-derived growth factorBlood+3.080.000
113SLC4A1solute carrier family 4 (anion exchanger), member 1 (Diego blood group)Blood-3.080.000
114MICAL2microtubule associated monooxygenase, calponin and LIM domain containing 2Blood-3.070.000
115NRG1neuregulin 1Blood-3.060.000
116TNS1tensin 1Blood-3.050.000
117SNCAsynuclein, alpha (non A4 component of amyloid precursor)Blood-3.020.000
118SEL1L3sel-1 suppressor of lin-12-like 3 (C. elegans)Blood+3.020.000
119IGLV6-57immunoglobulin lambda variable 6-57Blood+3.010.000
120DEPDC1DEP domain containing 1Blood+3.010.000

Search GEO for disease gene expression data for Dengue Hemorrhagic Fever.

Pathways for genes affiliated with Dengue Hemorrhagic Fever

About this section

Pathways related to Dengue Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show top 50)    (show all 51)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.6IL10, IL6, TNF
2
Show member pathways
9.6IFNG, IL10, TNF
3
Show member pathways
9.6HLA-A, IFNG, TNF
49.5IFNG, IL6, TNF
59.5CXCL8, IL6, TNF
69.4IFNG, STAT1, TNF
79.3CXCL8, IFNG, IL6
8
Salmonella infection (KEGG)
Show member pathways
9.3CXCL8, IFNG, IL6
99.3CD40LG, CXCL8, TNF
109.3CXCL8, IL6, STAT1
119.2IFNG, IL10, IL6, TNF
129.2IFNG, IL10, IL6, TNF
139.2CXCL8, IL10, IL6, TNF
149.1CXCL8, IFNG, IL6, TNF
159.1CXCL8, IFNG, IL6, TNF
16
Show member pathways
9.0ALB, F2, IFNG, IL6, TNF
17
Show member pathways
8.9CD40LG, CXCL8, IFNG, TNF
188.9CXCL8, F3, IL10, IL6, TNF
198.9CXCL8, IFNG, IL6, STAT1
208.9CD209, FCGR2A, HLA-A, HLA-B
218.9CXCL8, FCGR2A, IFNG, IL6, TNF
228.8CXCL8, IFNG, IL10, IL6, TNF
238.8IL6, STAT1, STAT2, TNF
24
Show member pathways
8.8IFNG, IL6, STAT1, TLR3
258.8HLA-A, HLA-B, IL6, TNF
26
B cell receptor signaling pathway (KEGG)
Show member pathways
8.7HLA-A, HLA-B, IL6, TNF
278.7HLA-A, HLA-B, IFNG, IL10
288.7IFNG, IL6, STAT1, STAT2
29
Show member pathways
8.7CXCL8, IFNG, IL6, STAT1, TNF
308.5IFNG, IL6, STAT1, TLR3, TNF
31
Show member pathways
8.5F2, IFNG, IL10, IL6, STAT1, TNF
328.5FCGR2A, IFNG, STAT1, STAT2, TNF
33
Show member pathways
8.4IFNG, IL10, IL6, STAT1, STAT2
34
Show member pathways
8.4CD40LG, FCGR2A, IFNG, IL10, STAT1, TNF
358.3CD209, FCGR2A, IFNG, IL10, IL6, STAT1
368.3CD40LG, CXCL8, IFNG, IL10, IL6, TNF
378.2CXCL8, STAT1, STAT2, TLR3, TNF
388.2HLA-B, IFNG, STAT1, STAT2
39
Show member pathways
8.1CXCL8, IFNG, IL6, STAT1, TLR3, TNF
40
Show member pathways
8.0CD209, CXCL8, F3, IL6, STAT1, TLR3
41
Show member pathways
7.9HLA-A, HLA-B, IFNG, STAT1, STAT2
42
Show member pathways
7.6IFNG, IL10, IL6, STAT1, STAT2, TLR3
43
Show member pathways
7.5CXCL8, F2, IFNG, IL10, IL6, STAT1
447.5CD40LG, IFNG, IL10, STAT1, STAT2, TLR3
45
Show member pathways
7.2CXCL8, IFNG, IL10, IL6, STAT1, STAT2
46
Show member pathways
7.1CD40LG, HLA-A, HLA-B, IFNG, IL10, IL6
47
Show member pathways
7.1CD40LG, CXCL8, IL10, IL6, STAT1, STAT2
48
Show member pathways
6.6CXCL8, HLA-A, HLA-B, IFNG, IL10, IL6
49
Show member pathways
6.2CD209, CXCL8, HLA-A, HLA-B, IFNG, IL6
50
Show member pathways
5.8CD209, CD40LG, FCGR2A, HLA-A, HLA-B, IFNG

GO Terms for genes affiliated with Dengue Hemorrhagic Fever

About this section

Cellular components related to Dengue Hemorrhagic Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:004261210.0HLA-A, HLA-B
2external side of plasma membraneGO:00098979.4CD40LG, IFNG, IL6, TNF
3cell surfaceGO:00099867.8CD209, F3, HLA-A, HLA-B, TLR3, TNF
4extracellular spaceGO:00056157.5ALB, CD40LG, CXCL8, F2, F3, IFNG

Biological processes related to Dengue Hemorrhagic Fever according to GeneCards Suite gene sharing:

(show all 49)
idNameGO IDScoreTop Affiliating Genes
1receptor biosynthetic processGO:003280010.7IL10, TNF
2response to inactivityGO:001485410.7F2, IL10
3positive regulation of vitamin D biosynthetic processGO:006055710.6IFNG, TNF
4negative regulation of cytokine secretion involved in immune responseGO:000274010.6IL10, TNF
5epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.6IL6, TNF
6positive regulation of calcidiol 1-monooxygenase activityGO:006055910.6IFNG, TNF
7negative regulation of lipid storageGO:001088810.6IL6, TNF
8neutrophil apoptotic processGO:000178110.5IFNG, IL6
9positive regulation of membrane protein ectodomain proteolysisGO:005104410.5IFNG, TNF
10positive regulation of MHC class II biosynthetic processGO:004534810.5IFNG, IL10
11necroptotic signaling pathwayGO:009752710.4TLR3, TNF
12regulation of immunoglobulin secretionGO:005102310.3CD40LG, TNF
13response to molecule of bacterial originGO:000223710.2CXCL8, IL10
14response to woundingGO:000961110.2F2, F3, IL6
15positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.2IL10, IL6, TNF
16positive regulation of protein kinase B signalingGO:005189710.2F3, IL6, TNF
17response to glucocorticoidGO:005138410.1IL10, IL6, TNF
18negative regulation of growth of symbiont in hostGO:004413010.1IFNG, IL10, TNF
19humoral immune responseGO:000695910.1IFNG, IL6, TNF
20antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.1HLA-A, HLA-B
21antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentGO:000248610.1HLA-A, HLA-B
22positive regulation of T cell mediated cytotoxicityGO:000191610.0HLA-A, HLA-B
23positive regulation of chemokine productionGO:003272210.0IL6, TLR3, TNF
24detection of bacteriumGO:001604510.0HLA-A, HLA-B
25defense response to protozoanGO:004283210.0IFNG, IL10, IL6
26protection from natural killer cell mediated cytotoxicityGO:004227010.0HLA-A, HLA-B
27positive regulation of chemokine biosynthetic processGO:004508010.0IFNG, TLR3, TNF
28extrinsic apoptotic signaling pathwayGO:009719110.0IFNG, TLR3, TNF
29defense response to Gram-positive bacteriumGO:005083010.0HLA-A, IL6, TNF
30positive regulation of smooth muscle cell proliferationGO:00486619.9IL6, STAT1, TNF
31positive regulation of nitric oxide biosynthetic processGO:00454299.9IFNG, IL6, TNF
32positive regulation of interleukin-6 productionGO:00327559.8IL6, TLR3, TNF
33positive regulation of interleukin-12 productionGO:00327359.6CD40LG, IFNG, TLR3
34response to lipopolysaccharideGO:00324969.6F3, IL10, IL6, STAT1
35defense response to bacteriumGO:00427429.4IFNG, IL10, TLR3, TNF
36antigen processing and presentationGO:00198829.3CD209, HLA-A, HLA-B, IFNG
37defense responseGO:00069529.3HLA-B, TLR3, TNF
38positive regulation of gene expressionGO:00106289.2IFNG, IL6, TLR3, TNF
39interferon-gamma-mediated signaling pathwayGO:00603339.1HLA-A, HLA-B, IFNG, STAT1
40positive regulation of transcription, DNA-templatedGO:00458939.1IFNG, IL10, IL6, STAT1, TNF
41type I interferon signaling pathwayGO:00603378.9HLA-A, HLA-B, STAT1, STAT2
42cellular response to lipopolysaccharideGO:00712228.8CXCL8, IFNG, IL10, IL6, STAT1, TNF
43platelet activationGO:00301688.7ALB, CD40LG, F2, IL6
44regulation of immune responseGO:00507768.6CD40LG, HLA-A, HLA-B, IFNG
45inflammatory responseGO:00069548.6CD40LG, CXCL8, IL10, IL6, TLR3, TNF
46defense response to virusGO:00516078.5IFNG, IL6, STAT1, STAT2, TLR3
47positive regulation of transcription from RNA polymerase II promoterGO:00459448.3IFNG, IL10, IL6, STAT1, TLR3, TNF
48immune responseGO:00069557.6CD40LG, CXCL8, HLA-A, HLA-B, IFNG, IL10
49cytokine-mediated signaling pathwayGO:00192217.5F3, HLA-A, HLA-B, IFNG, IL6, STAT1

Molecular functions related to Dengue Hemorrhagic Fever according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1TAP bindingGO:00469779.8HLA-A, HLA-B
2tumor necrosis factor receptor bindingGO:00051649.5CD40LG, STAT1, TNF
3peptide antigen bindingGO:00426059.1CD209, HLA-A, HLA-B
4cytokine activityGO:00051258.4CD40LG, IFNG, IL10, IL6, TNF

Sources for Dengue Hemorrhagic Fever

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet